Mark Heise
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
Papers in
-
- Metabolism, Diabetes, and Cancer 11
- Peroxisome Proliferator-Activated Receptors 9
-
- Diabetes Treatment and Management 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Diabetes Management and Research 2
- Co-authors
- Giancarlo Viberti (5 shared papers)Steven E. Kahn (7 shared papers)Bernard Zinman (5 shared papers)Steven M. Haffner (5 shared papers)Rury R. Holman (5 shared papers)John M. Lachin (6 shared papers)William H. Herman (5 shared papers)Barbara G. Kravitz (5 shared papers)
- Journals
- Diabetologia (3 papers)Diabetic Medicine (2 papers)Journal of the American Society of Nephrology (2 papers)Diabetes Care (2 papers)Diabetes Research and Clinical Practice (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Heise
24 papers receiving 3.4k citations
Mark Heise's Hit Papers
Peers
Comparison fields: 5 of 96
- Endocrinology, Diabetes and Metabolism 2.6k
- Molecular Biology 2.0k
- Orthopedics and Sports Medicine 221
- Surgery 936
- Pharmacology 322
Countries citing papers authored by Mark Heise
This map shows the geographic impact of Mark Heise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Heise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Heise more than expected).
Fields of papers citing papers by Mark Heise
This network shows the impact of papers produced by Mark Heise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Heise. The network helps show where Mark Heise may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Heise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2202 |
| 2 | 2008 | 411 | |
| 3 | 2003 | 201 | |
| 4 | 2002 | 193 | |
| 5 | 2004 | 143 | |
| 6 | 2006 | 85 | |
| 7 | 2004 | 58 | |
| 8 | 2005 | 52 | |
| 9 | 2015 | 45 | |
| 10 | 2006 | 35 | |
| 11 | 2008 | 34 | |
| 12 | 2000 | 29 | |
| 13 | 2022 | 12 | |
| 14 | 2002 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2000 | 8 | |
| 17 | 2011 | 6 | |
| 18 | 1996 | 5 | |
| 19 | 1995 | 4 | |
| 20 | Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain | 2007 | 2 |
About Mark Heise
Mark Heise is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 3.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Metabolism, Diabetes, and Cancer (11 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Diabetes and associated disorders (3 papers), Diabetes Management and Research (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.6k citations), Molecular Biology (2.0k citations), Orthopedics and Sports Medicine (221 citations), Surgery (936 citations) and Pharmacology (322 citations). Mark Heise has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Giancarlo Viberti, Steven E. Kahn, Bernard Zinman, Steven M. Haffner, Rury R. Holman, John M. Lachin, William H. Herman, Barbara G. Kravitz, Mark O’Neill and Nigel C. Jones. Their work appears in journals such as Diabetologia, Diabetic Medicine, Journal of the American Society of Nephrology, Diabetes Care and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.